Cancer-fighting Strategy
A research team, supported in part by a Penn State University Clinical and Translational Science Institute pilot grant award and research funding from the National Cancer Institute, has developed a promising cancer-fighting strategy for "reactivating" genes that cause cancer tumors to shrink and die. The discovery may aid in the development of an innovative anti-cancer drug that effectively targets unhealthy, cancerous tissue without damaging healthy, non-cancerous tissue and vital organs.
Credit: National Center for Advancing Translational Sciences (NCATS), National Institutes of Health
Cancer-fighting Strategy
A research team, supported in part by a Penn State University Clinical and Translational Science Institute pilot grant award and research funding from the National Cancer Institute, has developed a promising cancer-fighting strategy for "reactivating" genes that cause cancer tumors to shrink and die. The discovery may aid in the development of an innovative anti-cancer drug that effectively targets unhealthy, cancerous tissue without damaging healthy, non-cancerous tissue and vital organs.
Credit: National Center for Advancing Translational Sciences (NCATS), National Institutes of Health